Author:
Kini Anush V.,P.B. Harish,Anand Monica,Ranjan Uma
Abstract
Background:
COVID-19 mortality rates vary widely across regions and sex/gender. Understanding the reasons behind such variation could help in developing suitable management strategies.
Methods:
This paper presents a comprehensive analysis of incidence and mortality rates on 2,331,363 cases and 46,239 deaths over a cumulative period of approximately 6.5 months from February to August 2020 across 411 districts of India in the age group 15-49. Together with health data from government surveys, we identify risk and protective factors across regions, socio-economic status, literacy, and sex. To obtain common indicators, we apply both machine learning techniques and statistical tests on different health factors. We also identify positive and negative correlates at multiple population scales by dividing the cohort into sub-cohorts formed from two Indian states that were further segregated by sex.
Results:
We show that males and females differ in their risk factors for mortality. While obesity (lasso regression coefficient: KA=0.5083, TN=0.318) is the highest risk factor for males, anemia (KA=0.3048, TN=0.046) is the highest risk factor for females. Further, anemia (KA=-0.0958, TN=-0.2104) is a protective factor for males, while obesity (KA=-0.0223, TN=-0.3081) is a protective factor for females.
Conclusion:
Districts with a high prevalence of obesity pose a significantly greater risk of severe COVID-19 outcomes in males. On the other hand, in females, the prevalence of anemia in districts is notably associated with a higher risk of severe COVID-19 outcomes. It is important to consider sex-wise heterogeneity in health factors for better management of health resources.
Publisher
Bentham Science Publishers Ltd.
Subject
Public Health, Environmental and Occupational Health,Community and Home Care,Health (social science)
Reference59 articles.
1. NCIRD.
for Disease Control C, Prevention, editors. Evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19.
2020.
Available from: https: //www.cdc.gov/coronavirus/2019-ncov/needextra-precautions/evidence-table.html
2. Chang MC, Park YK, Kim BO, Park D.
Risk factors for disease progression in COVID-19 patients.
BMC Infect Dis
2020;
20
(1)
: 445.
3. Lee S, Kim T, Lee E, et al.
Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the republic of Korea.
JAMA Intern Med
2020;
180
(11)
: 1447-52.
4. Liang W, Liang H, Ou L, et al.
Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19.
JAMA Internal Medicine
2020;
180
(8)
: 10819.
5. Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS.
Obesity and impaired metabolic health in patients with COVID-19.
Nat Rev Endocrinol
2020;
16
(7)
: 341-2.